Literature DB >> 6283868

Fibrolamellar hepatocarcinoma: radiology, management, and pathology.

L K Wong, D P Link, C F Frey, R H Ruebner, H Tesluk, N R Pimstone.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6283868     DOI： 10.2214/ajr.139.1.172

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  8 in total

1.  Mediastinal metastasis from a fibrolamellar hepatocellular carcinoma: Report of a case.

Authors:  Yoshinobu Ichiki; Kenji Sugio; Tetsuro Baba; Makiko Mizukami; Takeshi Oga; Mitsuhiro Takenoyama; Takeshi Hanagiri; Koji Okamoto; Koji Yamaguchi; Satoshi Katagiri; Masakazu Yamamoto; Kosei Yasumoto
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  Hepatic perfusion abnormalities after liver transplantation.

Authors:  B A Porter; E S Woodle; R E Ward
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

3.  Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor.

Authors:  D H Teitelbaum; S Tuttle; L C Carey; K P Clausen
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

Review 4.  Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature.

Authors:  S Saab; F Yao
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

5.  Fibrolamellar hepatocarcinoma: clinical, radiologic, and pathologic features.

Authors:  I R Francis; F P Agha; N W Thompson; D F Keren
Journal:  Gastrointest Radiol       Date:  1986

6.  Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma.

Authors:  J S Albaugh; E B Keeffe; W W Krippaehne
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

7.  Fibrolamellar carcinoma of the liver--a case report.

Authors:  T Imai; H Yokoi; T Noguchi; Y Kawarada; R Mizumoto
Journal:  Gastroenterol Jpn       Date:  1991-06

8.  Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.

Authors:  Laura E Moreno-Luna; Oscar Arrieta; Jorge García-Leiva; Braulio Martínez; Aldo Torre; Misael Uribe; Eucario León-Rodríguez
Journal:  BMC Cancer       Date:  2005-10-31       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.